Dihydropiridinic calcium-channel antagonists in the 2007 ESH/ESC hypertension guidelines

Giuseppe Mancia

doi:10.2165/00151642-200815020-00007

Dihydropiridinic calcium-channel antagonists in the 2007 ESH/ESC hypertension guidelines

Giuseppe Mancia

Fondazione Istituto Auxologico Italiano

Research output: Contribution to journal › Article › peer-review

Abstract

Blood pressure lowering per se provides a large proportion of the benefit associated with antihypertensive treatment. Blood pressure should be reduced to

Original language	English
Pages (from-to)	85-90
Number of pages	6
Journal	High Blood Pressure and Cardiovascular Prevention
Volume	15
Issue number	2
DOIs	https://doi.org/10.2165/00151642-200815020-00007
Publication status	Published - 2008

Keywords

Calcium antagonist
Clinical trials
Guidelines
Hypertension
Organ damage

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.2165/00151642-200815020-00007

Cite this

@article{b2a37fe61b4d485eba667f1459fb0343,

title = "Dihydropiridinic calcium-channel antagonists in the 2007 ESH/ESC hypertension guidelines",

abstract = "Blood pressure lowering per se provides a large proportion of the benefit associated with antihypertensive treatment. Blood pressure should be reduced to ",

keywords = "Calcium antagonist, Clinical trials, Guidelines, Hypertension, Organ damage",

author = "Giuseppe Mancia",

year = "2008",

doi = "10.2165/00151642-200815020-00007",

language = "English",

volume = "15",

pages = "85--90",

journal = "High Blood Pressure and Cardiovascular Prevention",

issn = "1120-9879",

publisher = "Adis International Ltd",

number = "2",

}

TY - JOUR

T1 - Dihydropiridinic calcium-channel antagonists in the 2007 ESH/ESC hypertension guidelines

AU - Mancia, Giuseppe

PY - 2008

Y1 - 2008

N2 - Blood pressure lowering per se provides a large proportion of the benefit associated with antihypertensive treatment. Blood pressure should be reduced to

AB - Blood pressure lowering per se provides a large proportion of the benefit associated with antihypertensive treatment. Blood pressure should be reduced to

KW - Calcium antagonist

KW - Clinical trials

KW - Guidelines

KW - Hypertension

KW - Organ damage

UR - http://www.scopus.com/inward/record.url?scp=48349136988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48349136988&partnerID=8YFLogxK

U2 - 10.2165/00151642-200815020-00007

DO - 10.2165/00151642-200815020-00007

M3 - Article

C2 - 23334876

AN - SCOPUS:48349136988

VL - 15

SP - 85

EP - 90

JO - High Blood Pressure and Cardiovascular Prevention

JF - High Blood Pressure and Cardiovascular Prevention

SN - 1120-9879

IS - 2

ER -

Dihydropiridinic calcium-channel antagonists in the 2007 ESH/ESC hypertension guidelines

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this